
|Videos|June 17, 2014
Observation Versus Treatment in Men with Prostate Cancer
Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men's treatment decisions after seeing a rise in their PSA levels.
Advertisement
Peter Yu, MD, director, Palo Alto Medical Foundation, president-elect, ASCO, discusses results of a review that examined men’s treatment decisions after seeing a rise in their PSA levels.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Priority Review to Gedatolisib for HR+, HER2-Negative Advanced Breast Cancer
2
Unique Pharmacy Technician Career Ladder Meets the Needs of a Growing Profession
3
Circulating Tumor Cells May Guide Use of Tarlatamab in Small Cell Lung Cancer
4
Pharmacists Can Implement Test-and-Treat Services in Their Practice Settings
5



















































































































































































































